Detection of biomolecules in the near-infrared spectral region via a fiber-optic immunosensor.
The design, development, and application of a fluorescent fiber-optic immunosensor (FFOI) procedure for the detection of antibody/antigen binding within the near-infrared (NIR) spectral region is reported. The technique was developed through the combined use of fiber-optics, semiconductor laser excitation, fluorescence detection, NIR dye, and immunochemical techniques. The antibody is immobilized on the FFOI's sensing tip and utilized as a recognition component for trace amounts of specific antigen. The FFOI is constructed to utilize antibody sandwich technique. Three individual immunoassays are reported. The first two assays utilize the FFOI and NN382, a commercial NIR dye, for the detection of human immunoglobulin G (IgG). In these assays, goat anti-human IgG antibody (GAHG) is immobilized on the sensitive terminal of the FFOI followed by the exposure of the antibody-coated terminal to human IgG. The probe is then introduced to GAHG labeled with NN382, generating a signal. The third assay utilizes the FFOI for the detection of trace amounts of Legionella pneumophila serogroup 1 (LPS1). In this assay, rabbit anti-LPS1 antibody is immobilized on the sensitive terminal of the FFOI followed by exposure to LPS1. The antigen-coated probe is then treated with monoclonal anti-LPS1 antibody followed by incubation with GAHG labeled with NN382. The assays are optimized to detect the corresponding antigen via the NIR-FFOI. Typical measurements are performed in 10-15 min. A 780-nm semiconductor laser provides the excitation of the immune complex and the resulting emission is detected by a 820-nm silicon photodiode detector. The intensity of the resulting fluorescence is directly proportional to the concentration of the antigen. Solutions of IgG and LPS1 with concentrations as low as 10(-11) M and 0.5 ng/ml, respectively, have been detected with a minimum interference.
Daneshvar
M I
MI
Department of Chemistry, Georgia State University, Atlanta 30303, USA. mid2@cdc.gov
Peralta
J M
JM
Casay
G A
GA
Narayanan
N
N
Evans
L
L
Patonay
G
G
Strekowski
L
L
D000818:Animals; D000937:Antigen-Antibody Reactions; D000942:Antigens, Bacterial / Q000032:analysis*; D015374:Biosensing Techniques / Q000379:methods*; D005069:Evaluation Studies as Topic; D005336:Fiber Optic Technology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007118:Immunoassay; D007074:Immunoglobulin G / Q000032:analysis*; D016952:Legionella pneumophila / Q000276:immunology*; D008027:Light; D009419:Nerve Tissue Proteins / Q000276:immunology; D055100:Optical Fibers; D011137:Polystyrenes; D011817:Rabbits; D012680:Sensitivity and Specificity; D019265:Spectroscopy, Near-Infrared / Q000379:methods*
D000942:Antigens, Bacterial; C029152:G-substrate; D007074:Immunoglobulin G; D009419:Nerve Tissue Proteins; D011137:Polystyrenes